New drug combination highly effective in children with leukaemia
APL is an acute leukaemia, meaning it develops quickly and requires immediate treatment
Read More
Tag: leukemia
AZ’ Calquence hits endpoints in late-stage leukemia trial
The success marks the second Calquence pivotal trial in CLL to meet its primary endpoint early.
Read More
AbbVie, Roche present positive Venclyxto results at ASCO
Venclyxto is a first-in-class targeted medicine designed to selectively bind and inhibit the B-cell lymphoma-2 protein.
Read More
FDA hits leukemia study with partial clinical hold
The FDA has placed a partial clinical hold on Xencor’s Phase I study of XmAb14045 on safety concerns.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
